Soligenix Receives European Patent for Formulation of Synthetic Hypericin to Treat Psoriasis Read more
Valeant Pharmaceuticals and EyeGate Enter into Licensing Agreement for EGP-437 Combination Product Read more
ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials Read more
CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement Read more